SARS-CoV-2 nsp14 exonuclease inactivation mutant sequences
SARS-CoV-2 was engineered to express mutations at the nsp14 exonuclease active site and catalytic pocket. Viral stocks were amplified in cells, and viral RNA from infected cell lysates was sequenced by Illumina.